- Title: Britain should be concerned at Chinese gene data harvesting, lawmaker says
- Date: 22nd July 2021
- Summary: LONDON, ENGLAND, UNITED KINGDOM (JULY 21, 2021) (REUTERS) (SOUNDBITE) (English) BRITISH CONSERVATIVE PARTY LAWMAKER ON FOREIGN AFFAIRS COMMITTEE, TOM TUGENDHAT, SAYING: "I'm always concerned when data leaves the United Kingdom, that it should be treated with the respect and privacy that we would expect here at home, and the concern that this raises is that it may not be so, and your report made that clear." WHITE FLASH (SOUNDBITE) (English) BRITISH CONSERVATIVE PARTY LAWMAKER ON FOREIGN AFFAIRS COMMITTEE, TOM TUGENDHAT, SAYING: "It's certainly true that the connections between Chinese genomics firms and the Chinese military... do not align with what we would normally expect in the United Kingdom, or indeed many other countries, of the kind of collaboration that we expect to see. We expect science collaboration to be on the basis of open scientific endeavour. We don't expect it to be in terms of narrow national advantage, and that's what raises concerns here as well." WHITE FLASH (SOUNDBITE) (English) BRITISH CONSERVATIVE PARTY LAWMAKER ON FOREIGN AFFAIRS COMMITTEE, TOM TUGENDHAT, SAYING: "I think this is a topic of very serious debate because privacy, whether that's genetic privacy or personal privacy, is essential if we're going to have free societies and not simply a surveillance autocracy." WHITE FLASH (SOUNDBITE) (English) BRITISH CONSERVATIVE PARTY LAWMAKER ON FOREIGN AFFAIRS COMMITTEE, TOM TUGENDHAT, SAYING: "This is a moment of national debate. We regularly have national debate into what does privacy mean, what does security mean, and how should my rights or your rights be guarded, at the same time as guaranteeing that we get a benefit for the whole community and general knowledge about illnesses in human communities. So this is one of those moments where we need to have that debate because having that debate between ourselves is essential to knowing what we can or can't share with businesses around the world, and indeed with state-owned enterprises in China." WHITE FLASH (SOUNDBITE) (English) BRITISH CONSERVATIVE PARTY LAWMAKER ON FOREIGN AFFAIRS COMMITTEE, TOM TUGENDHAT, SAYING: "And so I think if any company is (using these tests) then they should make it extremely clear where the data is going, who is holding it and what access others, including other governments, will have to it. Unless a company has done that, I think it's perfectly reasonable for British people to be extremely concerned with these connections."
- Embargoed: 5th August 2021 10:45
- Keywords: BGI Group Britain China Tom Tugendhat UK genomics prenatal test surveillance women
- Location: VARIOUS
- City: VARIOUS
- Country: United Kingdom
- Topics: Europe,Government/Politics
- Reuters ID: LVA002EMXB22V
- Aspect Ratio: 16:9
- Story Text: The harvesting of data on the genomics of millions of women by a Chinese company through prenatal tests is concerning and Britain should debate how privacy can be protected from "surveillance autocracy," a senior British lawmaker told Reuters.
A Reuters review of scientific papers and company statements found that the Beijing Genomics Institute (BGI) Group developed the tests in collaboration with the Chinese military and is using them to collect genetic data for sweeping research on the traits of populations.
"I'm always concerned when data leaves the United Kingdom, that it should be treated with the respect and privacy that we would expect here at home, and the concern that this raises is that it may not be so," Tom Tugendhat, chair of the British parliament's Foreign Affairs Select Committee, said on Wednesday (July 21).
"The connections between Chinese genomics firms and the Chinese military do not align with what we would normally expect in the United Kingdom or indeed many other countries."
The privacy policy on the website for the Non-Invasive Prenatal Test (NIPT), sold under the brand name NIFTY in Britain, says data collected can be shared when it is "directly relevant to national security or national defense security" in China.
BGI says it has never shared data for national security purposes and has never been asked to.
The company said that it fully complied with European GDPR data protection rules and also had the British certification for personal information management.
"BGI's NIPT test was developed solely by BGI - not in partnership with China's military. All NIPT data collected overseas are stored in BGI's labs in Hong Kong and are destroyed after five years," it said in an email to Reuters, adding that it took data protection, privacy and ethics extremely seriously.
Tugendhat is one of nine British lawmakers who has been sanctioned by China for highlighting alleged human rights abuses in Xinjiang, which Beijing describes as "lies and disinformation."
He co-leads the China Research Group, a group of Conservative lawmakers which looks to rebalance the strategic relationship with China.
Tugendhat said he was concerned that genomic data could be collected for "narrow national advantage," adding that "the surveillance industry, in some countries, has got to the point where that does raise questions."
He said that any British companies using the tests should be clear where the data is going, who holds it, and what access others, including other governments, would have to it.
"Unless a company has done that, I think it's perfectly reasonable for British people to be extremely concerned with these connections," he said.
He highlighted the huge positive difference genomic tests could make in the world but said now was the moment for a debate over privacy that could reshape society.
"This is a topic of very serious debate because privacy, whether that's genetic privacy or personal privacy is essential if we're going to have free societies and not simply a surveillance autocracy," he said.
"Having that debate between ourselves is essential to knowing what we can or can't share with businesses around the world, and indeed with state-owned enterprises in China."
(Production: Lucy Marks) - Copyright Holder: REUTERS
- Copyright Notice: (c) Copyright Thomson Reuters 2021. Open For Restrictions - http://about.reuters.com/fulllegal.asp
- Usage Terms/Restrictions: None